Evaluation of cytotoxic T-lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus.
Cytotoxic T-lymphocyte (CTL) responses have been implicated as playing an important role in control of human immunodeficiency virus (HIV) infection. However, it is technically difficult to demonstrate CTL responses consistently in nonhuman primate and human subjects using traditional cytotoxicity assay methods. In this study, we systematically evaluated culture conditions that may affect the proliferation and expansion of CTL effector cells and presented a sensitive method for detection of cytotoxicity responses with bulk CTL cultures. We confirmed the sensitivity and specificity of this method by demonstration of vigorous CTL responses in a simian-HIV (SHIV)-infected rhesus macaque. The expansion of epitope-specific CTL effector cells was also measured quantitatively by CTL epitope-major histocompatibility complex tetramer complex staining. In addition, two new T-cell determinants in the SIV gag region are identified. Last, we showed the utility of this method for studying CTL responses in chimpanzee and human subjects.
Fu
T M
TM
Department of Virus and Cell Biology, Merck Research Laboratories, West Point, Pennsylvania 19486, USA. tong-ming_fu@merck.com
Freed
D C
DC
Trigona
W L
WL
Guan
L
L
Zhu
L
L
Long
R
R
Persaud
N V
NV
Manson
K
K
Dubey
S
S
Shiver
J W
JW
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000818:Animals; D015497:HIV-1; D006801:Humans; D015851:Interleukin-7 / Q000494:pharmacology; D008253:Macaca mulatta; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D015851:Interleukin-7